Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Antivenom market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Antivenom market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Antivenom market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Antivenom products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Antivenom products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Antivenom market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Antivenom development has been the leading industry trend of Antivenom market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Antivenom Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Polyvalent antivenom,Monovalent antivenom, Other |
| By Application Outlook |
Retail Pharmacies,Hospitals,Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
CSL Behring,Merck & Co.,BTG Plc,Pfizer,Haffkine Bio-Pharmaceutical Corporation,Rare Disease Therapeutics,Flynn Pharma,Vins Bioproducts,Bharat Serums and Vaccines,Serum Biotech |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- CSL Behring
- Merck & Co.
- BTG Plc
- Pfizer
- Haffkine Bio-Pharmaceutical Corporation
- Rare Disease Therapeutics
- Flynn Pharma
- Vins Bioproducts
- Bharat Serums and Vaccines
- Serum Biotech
Antivenom Market, By Type
- Polyvalent antivenom
- Monovalent antivenom
- Other
Antivenom Market, By Application
- Retail Pharmacies
- Hospitals
- Others
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
Global Antivenom Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 Antivenom Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Antivenom Industry Overview
2.1 Global Antivenom Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Antivenom Global Import Market Analysis
2.1.2 Antivenom Global Export Market Analysis
2.1.3 Antivenom Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Polyvalent antivenom
2.2.2 Monovalent antivenom
2.3.2 Hospitals
2.3.3 Others
2.4.2 Global Antivenom Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Antivenom Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Antivenom Manufacturer Market Share
2.4.5 Top 10 Antivenom Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Antivenom Market
2.4.7 Key Manufacturers Antivenom Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Antivenom Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Antivenom Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Antivenom Market Size Categorized by Regions
4.1 Global Antivenom Revenue, Sales and Market Share by Regions
4.1.1 Global Antivenom Sales and Market Share by Regions (2015-2020)
4.1.2 Global Antivenom Revenue and Market Share by Regions (2015-2020)
4.2 Europe Antivenom Sales and Growth Rate (2015-2020)
4.3 APAC Antivenom Sales and Growth Rate (2015-2020)
4.4 North America Antivenom Sales and Growth Rate (2015-2020)
4.5 South America Antivenom Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Antivenom Sales and Growth Rate (2015-2020)
5 Europe Antivenom Market Size Categorized by Countries
5.1 Europe Antivenom Sales, Revenue and Market Share by Countries
5.1.1 Europe Antivenom Sales by Countries (2015-2020)
5.1.2 Europe Antivenom Revenue by Countries (2015-2020)
5.1.3 Germany Antivenom Sales and Growth Rate (2015-2020)
5.1.4 UK Antivenom Sales and Growth Rate (2015-2020)
5.1.5 France Antivenom Sales and Growth Rate (2015-2020)
5.1.6 Russia Antivenom Sales and Growth Rate (2015-2020)
5.1.7 Italy Antivenom Sales and Growth Rate (2015-2020)
5.1.8 Spain Antivenom Sales and Growth Rate (2015-2020)
5.2 Europe Antivenom Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Antivenom Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Antivenom Sales Market Share by Type (2015-2020)
5.3.2 Europe Antivenom Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Antivenom Sales Market Share by Application (2015-2020)
6 Asia-Pacific Antivenom Market Size Categorized by Countries
6.1 Asia-Pacific Antivenom Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Antivenom Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Antivenom Revenue by Countries (2015-2020)
6.1.3 China Antivenom Sales and Growth Rate (2015-2020)
6.1.4 Japan Antivenom Sales and Growth Rate (2015-2020)
6.1.5 Korea Antivenom Sales and Growth Rate (2015-2020)
6.1.6 India Antivenom Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Antivenom Sales and Growth Rate (2015-2020)
6.1.8 Australia Antivenom Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Antivenom Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Antivenom Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Antivenom Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Antivenom Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Antivenom Sales and Market Share by Application (2015-2020)
7 North America Antivenom Market Size Categorized by Countries
7.1 North America Antivenom Sales, Revenue and Market Share by Countries
7.1.1 North America Antivenom Sales by Countries (2015-2020)
7.1.2 North America Antivenom Revenue by Countries (2015-2020)
7.1.3 United States Antivenom Sales and Growth Rate (2015-2020)
7.1.4 Canada Antivenom Sales and Growth Rate (2015-2020)
7.1.5 Mexico Antivenom Sales and Growth Rate (2015-2020)
7.2 North America Antivenom Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Antivenom Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Antivenom Sales Market Share by Type (2015-2020)
7.3.2 North America Antivenom Revenue and Revenue Share by Type (2015-2020)
7.4 North America Antivenom Sales Market Share by Application (2015-2020)
8 South America Antivenom Market Size Categorized by Countries
8.1 South America Antivenom Sales, Revenue and Market Share by Countries
8.1.1 South America Antivenom Sales by Countries (2015-2020)
8.1.2 South America Antivenom Revenue by Countries (2015-2020)
8.1.3 Brazil Antivenom Sales and Growth Rate (2015-2020)
8.2 South America Antivenom Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Antivenom Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Antivenom Sales Market Share by Type (2015-2020)
8.3.2 South America Antivenom Revenue and Revenue Share by Type (2015-2020)
8.4 South America Antivenom Sales Market Share by Application (2015-2020)
9 Middle East and Africa Antivenom Market Size Categorized by Countries
9.1 Middle East and Africa Antivenom Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Antivenom Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Antivenom Revenue by Countries (2015-2020)
9.1.3 GCC Countries Antivenom Sales and Growth Rate (2015-2020)
9.1.4 Turkey Antivenom Sales and Growth Rate (2015-2020)
9.1.5 Egypt Antivenom Sales and Growth Rate (2015-2020)
9.1.6 South Africa Antivenom Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Antivenom Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Antivenom Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Antivenom Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Antivenom Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Antivenom Sales Market Share by Application (2015-2020)
10 Global Antivenom Market Segment by Type
10.1 Global Antivenom Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Antivenom Sales and Market Share by Type (2015-2020)
10.1.2 Global Antivenom Revenue and Market Share by Type (2015-2020)
10.2 Polyvalent antivenom Sales Growth Rate and Price
10.2.1 Global Polyvalent antivenom Sales Growth Rate (2015-2020)
10.2.2 Global Polyvalent antivenom Price (2015-2020)
10.3 Monovalent antivenom Sales Growth Rate and Price
10.3.1 Global Monovalent antivenom Sales Growth Rate (2015-2020)
10.3.2 Global Monovalent antivenom Price (2015-2020)
11.1 Global AntivenomSales Market Share by Application (2015-2020)
11.2 Retail Pharmacies Sales Growth Rate (2015-2020)
11.3 Hospitals Sales Growth Rate (2015-2020)
11.4 Others Sales Growth Rate (2015-2020)
12.1 Global Antivenom Revenue, Sales and Growth Rate (2020-2027)
12.2 Antivenom Market Forecast by Regions (2020-2027)
12.2.1 Europe Antivenom Market Forecast (2020-2027)
12.2.2 APAC Antivenom Market Forecast (2020-2027)
12.2.3 North America Antivenom Market Forecast (2020-2027)
12.2.4 South America Antivenom Market Forecast (2020-2027)
12.2.5 Middle East & Africa Antivenom Market Forecast (2020-2027)
12.3 Antivenom Market Forecast by Type (2020-2027)
12.3.1 Global Antivenom Sales Forecast by Type (2020-2027)
12.3.2 Global Antivenom Market Share Forecast by Type (2020-2027)
12.4 Antivenom Market Forecast by Application (2020-2027)
12.4.1 Global Antivenom Sales Forecast by Application (2020-2027)
12.4.2 Global Antivenom Market Share Forecast by Application (2020-2027)
13 Analysis of Antivenom Industry Key Manufacturers
13.1 CSL Behring
13.1.1 Company Details
13.1.2 Product Information
13.1.3 CSL Behring Antivenom Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 CSL Behring News
13.2 Merck & Co.
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Merck & Co. Antivenom Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Merck & Co. News
13.3 BTG Plc
13.3.1 Company Details
13.3.2 Product Information
13.3.3 BTG Plc Antivenom Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 BTG Plc News
13.4 Pfizer
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Pfizer Antivenom Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Pfizer News
13.5 Haffkine Bio-Pharmaceutical Corporation
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Haffkine Bio-Pharmaceutical Corporation Antivenom Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Haffkine Bio-Pharmaceutical Corporation News
13.6 Rare Disease Therapeutics
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Rare Disease Therapeutics Antivenom Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Rare Disease Therapeutics News
13.7 Flynn Pharma
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Flynn Pharma Antivenom Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Flynn Pharma News
13.8 Vins Bioproducts
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Vins Bioproducts Antivenom Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Vins Bioproducts News
13.9 Bharat Serums and Vaccines
13.9.1 Company Details
13.9.2 Product Information
13.9.3 Bharat Serums and Vaccines Antivenom Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 Bharat Serums and Vaccines News
13.10 Serum Biotech
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Serum Biotech Antivenom Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 Serum Biotech News
15 Appendix
